Adjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option?
Date
2020-09
Language
English
Embargo Lift Date
Department
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
ASCO
Abstract
Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Einhorn, L. H., Adra, N., Hanna, N., & Nichols, C. (2020). Adjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option? Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 38(26), 3073–3074. https://doi.org/10.1200/JCO.20.00702
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Journal of Clinical Oncology
Rights
Source
Publisher
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
Version
Final published version